133 related articles for article (PubMed ID: 35339128)
1. The association between bullous pemphigoid and comorbidities: a case-control study in Moroccan patients.
Titou H; Kerrouch H; Frikh R; Hjira N
Acta Dermatovenerol Alp Pannonica Adriat; 2022 Mar; 31(1):7-11. PubMed ID: 35339128
[TBL] [Abstract][Full Text] [Related]
2. Comorbidities of bullous pemphigoid in a Finnish cohort.
Pankakoski A; Sintonen H; Ranki A; Kluger N
Eur J Dermatol; 2018 Apr; 28(2):157-161. PubMed ID: 29619987
[TBL] [Abstract][Full Text] [Related]
3. The association between neurological diseases, malignancies and cardiovascular comorbidities among patients with bullous pemphigoid: Case-control study in a specialized Polish center.
Kalińska-Bienias A; Kowalczyk E; Jagielski P; Bienias P; Kowalewski C; Woźniak K
Adv Clin Exp Med; 2019 May; 28(5):637-642. PubMed ID: 30784240
[TBL] [Abstract][Full Text] [Related]
4. Association of bullous pemphigoid and comorbid health conditions: a case-control study.
Lee S; Rastogi S; Hsu DY; Nardone B; Silverberg JI
Arch Dermatol Res; 2021 Jul; 313(5):327-332. PubMed ID: 32647978
[TBL] [Abstract][Full Text] [Related]
5. Mortality and prognostic factors of Bullous Pemphigoid in a Moroccan population.
Titou H; Hjira N
Australas J Dermatol; 2022 Aug; 63(3):328-334. PubMed ID: 35500129
[TBL] [Abstract][Full Text] [Related]
6. Multimorbidity in bullous pemphigoid: a case-control analysis of bullous pemphigoid patients with age- and gender-matched controls.
Sim B; Fook-Chong S; Phoon YW; Koh HY; Thirumoorthy T; Pang SM; Lee HY
J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1709-1714. PubMed ID: 28485892
[TBL] [Abstract][Full Text] [Related]
7. Comorbidities of bullous pemphigoid: A single-center retrospective case-control study from Turkey.
Kılıç Sayar S; Sun GP; Küçükoğlu R
Dermatol Ther; 2021 Sep; 34(5):e15031. PubMed ID: 34137146
[TBL] [Abstract][Full Text] [Related]
8. Bullous pemphigoid and comorbidities: a case-control study in Portuguese patients.
Teixeira VB; Cabral R; Brites MM; Vieira R; Figueiredo A
An Bras Dermatol; 2014; 89(2):274-8. PubMed ID: 24770504
[TBL] [Abstract][Full Text] [Related]
9. Comorbid diseases among bullous pemphigoid patients in Germany: new insights from a case-control study.
Martin E; Mauer I; Malzahn U; Heuschmann PU; Goebeler M; Benoit S
J Dtsch Dermatol Ges; 2022 Jun; 20(6):798-805. PubMed ID: 35657083
[TBL] [Abstract][Full Text] [Related]
10. Increased frequency of multiple sclerosis among patients with bullous pemphigoid: a population-based cohort study on comorbidities anchored around the diagnosis of bullous pemphigoid.
Kibsgaard L; Rasmussen M; Lamberg A; Deleuran M; Olesen AB; Vestergaard C
Br J Dermatol; 2017 Jun; 176(6):1486-1491. PubMed ID: 28235244
[TBL] [Abstract][Full Text] [Related]
11. A History of Asthma Increases the Risk of Bullous Pemphigoid: Insights from a Large Population-Based Study.
Kridin K; Ludwig RJ; Tzur Bitan D; Cohen AD
Dermatology; 2021; 237(6):921-928. PubMed ID: 33640889
[TBL] [Abstract][Full Text] [Related]
12. Association of Bullous Pemphigoid With Dipeptidyl-Peptidase 4 Inhibitors in Patients With Diabetes: Estimating the Risk of the New Agents and Characterizing the Patients.
Kridin K; Bergman R
JAMA Dermatol; 2018 Oct; 154(10):1152-1158. PubMed ID: 30090931
[TBL] [Abstract][Full Text] [Related]
13. Association between bullous pemphigoid and atopic dermatitis: a population-based case-control study in Taiwan.
Wu PC; Wu CY; Lyu YS; Chang YT; Wu CY
Arch Dermatol Res; 2023 Apr; 315(3):419-427. PubMed ID: 35834038
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, Spectrum and Clinical Implications of Malignancies in Patients with Bullous Pemphigoid.
Baum S; Steinberg S; Tzanani I; Barzilai A; Lyakhovitsky A
Acta Derm Venereol; 2023 Mar; 103():adv00888. PubMed ID: 36916952
[TBL] [Abstract][Full Text] [Related]
15. Bullous pemphigoid and diabetes mellitus: a systematic review and meta-analysis.
Jiirasutat N; Pongchareon P; Weschawalit S
Int J Dermatol; 2024 May; 63(5):572-579. PubMed ID: 38217028
[TBL] [Abstract][Full Text] [Related]
16. Neurological disorders are associated with bullous pemphigoid.
Papakonstantinou E; Limberg MM; Gehring M; Kotnik N; Kapp A; Gibbs BF; Raap U
J Eur Acad Dermatol Venereol; 2019 May; 33(5):925-929. PubMed ID: 30663128
[TBL] [Abstract][Full Text] [Related]
17. Association of Dipeptidyl Peptidase 4 Inhibitor Use With Risk of Bullous Pemphigoid in Patients With Diabetes.
Lee SG; Lee HJ; Yoon MS; Kim DH
JAMA Dermatol; 2019 Feb; 155(2):172-177. PubMed ID: 30624566
[TBL] [Abstract][Full Text] [Related]
18. Oral diabetes medications other than dipeptidyl peptidase 4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study.
Varpuluoma O; Försti AK; Jokelainen J; Turpeinen M; Timonen M; Tasanen K; Huilaja L
J Am Acad Dermatol; 2018 Dec; 79(6):1034-1038.e5. PubMed ID: 29803903
[TBL] [Abstract][Full Text] [Related]
19. Bullous pemphigoid and antecedent neurological diseases: An association with dementia.
Yu Phuan CZ; Yew YW; Tey HL
Indian J Dermatol Venereol Leprol; 2017; 83(4):457-461. PubMed ID: 28584223
[TBL] [Abstract][Full Text] [Related]
20. The impact of diabetes mellitus on medical complication and mortality rates among inpatients with bullous pemphigoid.
Patel S; Ahsanuddin S; Cadwell JB; Lambert WC
Ir J Med Sci; 2022 Aug; 191(4):1669-1675. PubMed ID: 34402030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
